Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd.

SZSE:300501.SZ

14.24 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011
Revenue 1,010.391,012.601856.858713.785621.03507.196375.617301.276293.978289.85277.367210.237149.003
Cost of Revenue 726.016740.934609.812469.975427.524341.493235.136184.72185.931188.197182.267139.11399.055
Gross Profit 284.374271.667247.046243.81193.507165.703140.481116.556108.048101.65395.171.12549.949
Gross Profit Ratio 0.2810.2680.2880.3420.3120.3270.3740.3870.3680.3510.3430.3380.335
Reseach & Development Expenses 47.57344.49132.87824.29426.43723.26416.86516.36216.77816.15715.70310.1360
General & Administrative Expenses 14.54614.88712.92416.47227.1213.16512.815.9015.1732.8293.2952.50916.213
Selling & Marketing Expenses 54.73145.60842.56150.96238.64531.7821.90314.43213.04513.52812.8610.2088.281
SG&A 117.1760.49555.48567.43465.76544.94434.71320.33318.21716.35616.15612.71724.494
Other Expenses -8.3490.24-0.352-0.7-0.8020.1230.9150.9282.1252.7070.890.1790.053
Operating Expenses 173.092149.095136.034127.938126.60992.0566.36947.84844.0540.55338.68129.07524.62
Operating Income 111.281122.683117.785119.44573.92976.87775.95772.98666.36761.19153.00641.03423.292
Operating Income Ratio 0.110.1210.1370.1670.1190.1520.2020.2420.2260.2110.1910.1950.156
Total Other Income Expenses Net -9.4890.24-0.352-0.7-0.8020.1230.9150.8762.1232.7070.8870.1610.026
Income Before Tax 101.792122.923117.434118.74473.1277776.87273.86268.4963.89853.89241.19523.319
Income Before Tax Ratio 0.1010.1210.1370.1660.1180.1520.2050.2450.2330.220.1940.1960.156
Income Tax Expense 14.64213.0718.40413.3177.39312.63611.1728.8949.7069.6079.4127.1363.528
Net Income 85.442102.461104.646102.90466.97666.16565.81164.60458.76754.22444.46634.05819.791
Net Income Ratio 0.0850.1010.1220.1440.1080.130.1750.2140.20.1870.160.1620.133
EPS 0.440.530.640.670.440.440.430.560.520.480.390.30.18
EPS Diluted 0.440.530.640.670.430.440.430.560.520.480.390.30.18
EBITDA 168.508182.461167.124164.267115.925105.43890.61583.00376.05468.61863.00948.15326.704
EBITDA Ratio 0.1670.180.1950.230.1870.2080.2410.2760.2590.2370.2270.2290.179